Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
Open Access
- 3 February 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 34
- https://doi.org/10.3389/fimmu.2015.00034
Abstract
Tryptophan is required for T lymphocyte effector functions. Its degradation is one of the mechanisms selected by tumors to resist immune destruction. Two enzymes, tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase 1 (IDO1), control tryptophan degradation through the kynurenine pathway. A third protein, indoleamine 2,3-dioxygenase 2 (IDO2), was identified more recently. All three enzymes were reported to be expressed in tumors, and are candidate targets for pharmacological inhibition aimed at restoring effective anti-tumoral immunity. In this review, we compare these three enzymes in terms of structure, activity, regulation and expression in healthy and cancerous tissues, in order to appreciate their relevance to tumoral immune resistance.Keywords
This publication has 75 references indexed in Scilit:
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis DevelopmentCancer Discovery, 2012
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune EscapeScience Translational Medicine, 2012
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenaseProceedings of the National Academy of Sciences of the United States of America, 2012
- Opposing Biological Functions of Tryptophan Catabolizing Enzymes During Intracellular InfectionThe Journal of Infectious Diseases, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active TargetJournal of the American College of Surgeons, 2009
- Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in miceMolecular Brain, 2009
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences of the United States of America, 2008